Innovative drug concept was active at the beginning of the session, with Staidson BioPharm rising over 15%
In the morning session, Staidson BioPharm surged over 15%, HC CHEMICAL hit the daily limit, and Hinova, Chengda Pharmaceutical, Zelgen, RemeGen, Hotgen, and BeiGene followed suit
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments